Annals of Biomedical Engineering

Annals of Biomedical Engineering is the monthly journal of the Biomedical Engineering Society, published by Springer since 1972, and it reports quantitative bioengineering and biomedical engineering research, with a 2025 Journal Impact Factor of 5.2.《生物医学工程年鉴》（Annals of Biomedical Engineering）是（Biomedical Engineering Society）的会刊，由（Springer）自 1972 年起出版，月刊，刊载定量化的生物工程与生物医学工程研究，2025 年期刊影响因子为 5.2。

Scope

• Original and review articles are published across the major fields of bioengineering and biomedical engineering, with no restriction to a single technique or organ system.刊物刊载生物工程与生物医学工程各主要领域的原创论文与综述，不局限于单一技术或器官系统。
• The stated aim is to provide integrated engineering approaches to biological and biomedical problems rather than isolated measurements.其宗旨是以工程学的综合方法解决生物学与生物医学问题，而非孤立地报告测量结果。
• A balance between experimental observation and quantitative analysis is the journal's declared philosophy.在实验观察与定量分析之间保持平衡，是刊物明确宣示的编辑理念。
• Theory and mathematical modelling are encouraged, provided the models are evaluated against biological data from experiments that test specific hypotheses.刊物鼓励理论与数学建模，但要求模型以检验特定假说的生物学实验数据加以评估。
• Research articles, review articles and letters to the editor are accepted, and special or guest-edited issues appear regularly.接受研究论文、综述与致编辑信，并定期出版专题或客座编辑专刊。
• There are no page charges and no fees for colour figures, whether printed or online.刊物不收版面费，纸本与在线的彩色图版也不另收费。
• Board members may submit, but their manuscripts go to another editor and receive no priority.编委可以投稿，但其稿件交由其他编辑处理，且不享有优先权。

History

• Volume 1, number 1 appeared in September 1972, and four issues carried that first volume into December 1973.第 1 卷第 1 期于 1972 年 9 月出版，该卷共 4 期，延续到 1973 年 12 月。
• It was quarterly at first, moved to six issues a year in the early 1980s, and has been monthly since volume 29 in 2001, with volume 54 covering 2026.早期为季刊，1980 年代初增至每年 6 期，自 2001 年第 29 卷起改为月刊，2026 年为第 54 卷。
• It is the flagship journal of the Biomedical Engineering Society and is published on the society's behalf.本刊是（Biomedical Engineering Society）的旗舰刊物，代表该学会出版。
• The 50th anniversary was marked in 2022, by which time the journal had published more than 6,000 research papers and accumulated some 15,000 citations.2022 年刊物纪念创刊五十周年，当时已发表逾 6000 篇研究论文，累计被引约 1.5 万次。^[1]
• Springer publishes it on a hybrid open access model, and 911 articles are already free to read in full.（Springer）以混合开放获取模式出版，目前已有 911 篇文章可免费阅读全文。
• The 2025 Journal Impact Factor is 5.2 with a five-year figure of 4.1, following 5.4 in 2024, 4.219 in 2022 and 3.934 in 2021, at Q2 rank 36 of 130 in biomedical engineering.2025 年期刊影响因子为 5.2，五年影响因子为 4.1，此前 2024 年为 5.4，2022 年为 4.219，2021 年为 3.934，在生物医学工程类别位列 Q2，排名 36/130。

Editors

• Joel D. Stitzel, professor and chair of biomedical engineering at Wake Forest University School of Medicine in Winston-Salem, is Editor-in-Chief, and his own research centres on injury biomechanics and occupant safety.主编为（Joel D. Stitzel），系温斯顿-塞勒姆（Wake Forest University School of Medicine）生物医学工程教授兼系主任，其本人的研究集中于损伤生物力学与乘员安全。
• Merryn Tawhai of the University of Auckland serves as Deputy Editor-in-Chief.副主编为奥克兰大学（University of Auckland）的（Merryn Tawhai）。
• Some 48 associate editors serve, based in the United States, Canada, the United Kingdom, China, Japan, South Korea, Brazil, Egypt, Israel, Italy, Spain, Switzerland, Norway, Hungary, Cyprus, Portugal and New Zealand.约 48 位副编辑任职，分别来自美国、加拿大、英国、中国、日本、韩国、巴西、埃及、以色列、意大利、西班牙、瑞士、挪威、匈牙利、塞浦路斯、葡萄牙与新西兰。
• Review is single-blind, with two referees and a handling editor per manuscript, no acceptance without two complete reviews and a final decision reserved to the Editor-in-Chief.评审采用单盲制，每篇稿件由两位审稿人与一位处理编辑评估，未经两份完整评审不予录用，最终决定权归主编。
• At most two revisions are allowed, and revised papers are usually returned to the original referees.稿件最多允许两次修改，修回稿通常交回原审稿人复评。
• The board reported more than 50 percent women editors in 2022, pioneered a diversity citation policy and awards the Athanasiou prize for the best paper by a student or postdoc.编委会在 2022 年报告女性编辑占比超过 50%，率先推行多元化引文政策，并设立（Athanasiou）奖奖励学生或博士后的最佳论文。